Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in reduc ...
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...
A team of scientists has uncovered a critical mechanism that could pave the way for safer and more effective obesity ...
A single type of chemical structure that shows up again and again in modern medicine is the amide bond that links a carbonyl ...
From the spice rack to the lab bench, emerging proteomic insights reveal how hidden peptide fragments in everyday spices may ...
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
Alzheimer's disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into ...
Visby Medical, a leading innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration with Watchmaker Genomics, a supplier of innovative products for molecular ...
Alzheimer's disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into ...
A live webcast of the presentation will be accessible on the Events page in the Investors section of the Company’s website at palisadebio.com. A replay will be available following the live event and ...
PITTSBURGH - A team of scientists has uncovered a critical mechanism that could pave the way for safer and more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results